Cancer and mTOR inhibitors in kidney transplantation recipients

BACKGROUND: Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. METHODS: In the current study, patients were registered in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Chih-Chin, Liu, Jia-Sin, Chang, Yu-Kang, Lin, Ming-Huang, Lin, Yen-Chung, Chen, Hsi-Hsien, Chang, Wei-Chiao, Hsu, Chih-Cheng, Wu, Mai-Szu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237112/
https://www.ncbi.nlm.nih.gov/pubmed/30473931
http://dx.doi.org/10.7717/peerj.5864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237112/
https://www.ncbi.nlm.nih.gov/pubmed/30473931
http://dx.doi.org/10.7717/peerj.5864

Ejemplares similares